FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Atropine Sulfate Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Anesthesia; Neurology; Pediatric

Expand all

American Regent/Luitpold (Reverified 11/12/2019)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25) Limited Availability American Regent is currently releasing the 0.4mg/mL, 1 mL vial, NDC 00517-0401-25 Demand increase for the drug
1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25) Limited Availability American Regent is currently releasing the 1mg/mL, 1 mL vial, (NDC 00517-1010-25) Other

Amphastar Pharmaceuticals, Inc./IMS (Revised 11/06/2019)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3339-1, Old NDC 0548-3339-00) Available

Fresenius Kabi USA, LLC (Revised 11/12/2019)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20) Available Check wholesaler inventory Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 09/12/2019)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.4 mg/mL, 20 mL vial (NDC 0641-6006-10) Hikma has inventory available. Additional lots are scheduled for manufacturing in the November – December 2019 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Revised 11/08/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe (NDC 0409-1630-10) Next Delivery: December 2019; Estimated Recovery: August 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other
0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe (NDC 0409-9630-05) Next Delivery: December 2019; Estimated Recovery: August 2020 Shortage per Manufacturer: Manufacturing Delay

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other
0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34) Next Delivery: November 2019; Estimated Recovery: August 2020 Shortage per Manufacturer: Manufacturing Delay

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other
1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34) Next Delivery: November 2019; Estimated Recovery: January 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English